Clinical Trials Browser

INDUSTRY × Advanced Malignancy × Clear all

NCT07123129 2026-01-30

A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors

Phase 1 Recruiting

Advanced Malignancy

NCT02978482 2021-08-18

A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies

Phase 1 Completed

Advanced Malignancy

NCT04216082 2020-01-02

A Study of Anlotinib in Subjects With Advanced Malignancy

Phase 2 Completed

Advanced Malignancy